CTNNB1 and cardiac hypertrophy: For Ctnnb1/Beta-catenin, a key molecule in pathways associated with cardiac hypertrophy, it has been shown that decreased expression levels are important for the process of adaptive left ventricular remodeling (62), suggesting that the predicted fine-tuning of these target mRNAs enhances physiological hypertrophy.